SAINT® Therapy for Memory Problems in Older Adults With Treatment-Resistant Depression
NCT07876908
This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .
Summary
The goal of this clinical trial is to learn whether Stanford Accelerated Intelligent Neuromodulation Therapy (SAINT®), a type of transcranial magnetic stimulation (TMS), is safe and may improve memory and thinking in adults aged 65 or older with treatment-resistant depression and memory concerns. Researchers will also study whether SAINT® improves depression symptoms. The main questions it aims to answer are: Does SAINT® improve memory and thinking five days after treatment? Does SAINT® improve depression symptoms and overall well-being?
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Depressive Disorder, Treatment-Resistant
- Memory Deficits
Eligibility basics and study details
- Study type
- Interventional
- Phase
- Not applicable
- Ages
- 65 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Sponsor
- BrainHealth Solutions, Inc.
- Last updated on ClinicalTrials.gov
- October 15, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
California · 1
- BrainHealth Solutions Inc. · Costa Mesa, CA
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.